Riskpilot← Back to searchSign inGet full accessBIOMETRICAL AS
ASActiveOrg 926927787Finnmarkgata 44, 0563 OsloComputer programming activities · NACE 6210Est. 20211 employees
Revenue 2024
NOK 1,4M
-36% vs 2023
EBITDA margin
18.5%
+128% vs 2023
Equity ratio
88.6%
Financial strength
Net profit 2024
NOK 255K
+129% vs 2023
| Revenue | NOK 1,4M | -36% |
| EBITDA | NOK 250K | +128% |
| Net profit | NOK 255K | +129% |
| Total assets | NOK 2,3M | +3% |
| Equity | NOK 2M | +15% |
| Employees | 1 | — |
Legal name
BIOMETRICAL AS
Org number
926927787
Legal form
Aksjeselskap
NACE code
6210 · Computer programming activities
Founded
12. april 2021
Share capital
NOK 102 228
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene eller to styremedlemmer i fellesskap.
Company purpose
Utvikling av programvare og trening av nevrale nettverk til bruk innen helseteknologi.
Address
Finnmarkgata 44, 0563 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 3 026 | 4 918 | 2 108 | 1 353 |
| Staff expenses | −1 708 | −3 744 | −2 621 | −751 |
| EBITDA | 1 129 | 948 | −886 | 250 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | 1 129 | 948 | −886 | 250 |
| Net financials | 1 | −16 | 8 | 5 |
| Profit before tax | 1 129 | 932 | −878 | 255 |
| Tax | 247 | 208 | −0 | −0 |
| Net profit | 882 | 724 | −878 | 255 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 2 681 | 3 881 | 2 193 | 2 256 |
| Equity | 1 899 | 2 623 | 1 745 | 2 000 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 782 | 1 258 | 448 | 256 |
| Total debt | 782 | 1 258 | 448 | 256 |
EBITDA margin
18.5%
This company
15.8%
Market median
+17% vs market
20212024
Equity ratio
88.6%
This company
38.2%
Market median
+132% vs market
20212024
Return on equity
12.8%
This company
18.4%
Market median
+30% vs market
20212024
Net profit margin
18.8%
This company
8.1%
Market median
+132% vs market
20212024
Asset turnover
0.60×
This company
1.12×
Market median
-46% vs market
20212024
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-03-08 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JS Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 14.29% | 14.29% | 2022 | |
| Company | 14.29% | 14.29% | 2022 | |
| Company | 14.29% | 14.29% | 2022 | |
| Company | 14.29% | 14.29% | 2022 | |
| Individual | 14.29% | 14.29% | 2022 | |
| Company | 14.29% | 14.29% | 2022 | |
| Individual | 14.29% | 14.29% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BIOMETRICAL AS 
PADELEYES ASBoard members of BIOMETRICAL AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jonas Skarstein Waaler | Chief Executive Officer | 0 companies |
| Felipe Longé | Board of Directors | 0 companies |
| Kurt Alexander Oen Bakkevig | Board of Directors | 0 companies |
| Kurt Alexander Bakkevig | Board of Directors | 0 companies |